AbrahamJ., & GulleyJ. L. (2018). The Bethesda handbook of clinical oncology (5th ed.). Lippincott Williams & Wilkins.
American College of Obstetricians and Gynecologists. (2016). Practice Bulletin No. 168: Cervical cancer screening and prevention. Obstetrics and Gynecology, 128(4), 923–925. Reaffirmed 2019.
American Cancer Society. (2020). American Cancer Society guidelines for the early detection of cancer. http://www.cancer.org/content/dam/CRC/PDF/Public/912.00.pdf
CibasE. S., & DucatmanB. S. (2020). Cytology: Diagnostic principles and clinical correlates (5th ed.). Elsevier.
DeVitaV. T., RosenbergS. A., & LawrenceT. S. (2018). Cancer: Principles and practice of oncology (11th ed.). Lippincott Williams & Wilkins.
FonthamE. T. H., WolfA. M. D., ChurchT. R., EtzioniR., FlowersC. R., HerzigA., GuerraC. E., OeffingerK. C., ShihY. C. T., WalterL. C., KimJ. J., AndrewsK. S., DeSantisC. E., FedewaS. A., Manassaram-BaptisteD., SaslowD., WenderR. C., & SmithR. A. (2020). Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. A Cancer Journal for Clinicians. http://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.3322/caac.21628
KlugW. S., CummingsM. R., SpencerC. A., PalladinoM. A., & KillianD. (2019). Essentials of genetics (10th ed.). Pearson.
LevineD. A., LinL., & GaillardS. (2020). Handbook for principles and practice of gynecologic oncology (3rd ed.). Lippincott Williams & Wilkins.
NayarR., & WilburD. C. (2015). The Bethesda system for reporting cervical cytology: Definitions, criteria, and explanatory notes (3rd ed.). Springer.
NiederhuberJ. E., ArmitageJ. O., DoroshowJ. H., KastanM. B., & TepperJ. E. (2019). Abeloff’s clinical oncology (6th ed.). Elsevier.
PerkinsR. B., GuidoR. S., CastleP. E., ChelmowD., EinsteinM. H., GarciaF., HuhW. K., KimJ. J., MoscickiA. B., NayarR., SaraiyaM., SawayaG. F., WentzensenN., SchiffmanM., & 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. (2020). 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Journal of Lower Genital Tract Disease, 24, 102–131. file:///C:/Users/Administrator/Downloads/2019_ASCCP_Risk_Based_Management_Consensus.3%20(5).pdf
PierceB. A. (2019). Genetics: A conceptual approach (7th ed.). W.H. Freeman.
US Preventative Services Task Force, CurryS. J., KristA. H., OwensD. K., BarryM. J., CaugheyA. B., DavidsonK. W., DoubeniC. A., EplingJ. W., KemperA. R., KubikM., LandefeldC. S., MangioneC. M., PhippsM. G., SilversteinM., SimonM. A., TsengC. W., & WongJ. B. (2018). Screening for cervical cancer: US preventive services task force recommendation statement. Journal of the American Medical Association, 320(7), 674–686. file:///C:/Users/Administrator/Downloads/cervical-cancer-final-rec-statement.pdf
WrightJ. R. (2020). Albert C. Broders, tumor grading, and the origin of the long road to personalized cancer care. Cancer Medicine, 9(13), 4490–4494.